Medical Oncologist and hematologist
Oncology
Dr. Soley Bayraktar, MD
|
|
Give Review
Doctor Soley Bayraktar, MD practices Oncology. She researched medicine at Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. She received 4 awards: "CMS Meaningful Use Stage 1 Certification", "Annual Meeting Merit Award", "Grant for AACR Molecular Biology in Clinical Oncology Workshop" and "Outstanding Academic Ambulatory Resident Award". Soley Bayraktar, MD is also published. She has 18 publications published. The lastest publication: "Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab ch...' She accepts Medicare.
Publications
- Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab ch...
- A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan.
- LMO2 and BCL6 are associated with improved survival in primary central nervous system Lymphoma.
- A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere.
- Molecularly targeted therapies for advanced or metastatic non-small-Cell lung carcinoma.
- Molecularly targeted therapies for metastatic triple-negative breast cancer.
- Emerging Cell-cycle inhibitors for pancreatic cancer therapy.
- Hepatic venous outflow obstruction: three similar Syndromes.
- Metastatic prostate cancer presenting as mediastinal lymphadenopathy identified by EUS with FNA.
- Lycopene and soy isoflavones in the treatment of prostate cancer.
- Dietary tomato powder supplementation in the prevention of leiomyoma of the oviduct in the Japanese quail.
- Lycopene in cancer prevention and treatment.
- Potential role of lycopene in the treatment of hepatitis C and prevention of hepatoCellular carcinoma.
- Chemoprevention of fibroid tumors by [-]-epigallocatechin-3-gallate in quail.
- Genistein suppresses spontaneous oviduct tumorigenesis in quail.
- The effects of selenium supplementation on the spontaneously occurring fibroid tumors of oviduct, 8-hydroxy-2''-deoxyguanosine levels, and heat shock protein 70 respon...
- The Relationship Between Eight GWAS-Identified Single-Nucleotide Polymorphisms and Primary Breast Cancer Outcomes.
Conditions Treated
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Deep Vein Thrombosis (DVT)
- Immune Thrombocytopenic Purpura (ITP)
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Annual Meeting Merit Award
- Grant for AACR Molecular Biology in Clinical Oncology Workshop
- Outstanding Academic Ambulatory Resident Award
Education
-
University of Massachusetts -
University of Texas Health Science Center -
Jackson Memorial Hospital - Jackson Health System -
Mount Sinai Medical Center of Florida -
Wayne State University School of Medicine
Drug Facts
| NPI NUMBER | 1437331493 | |
| NPPES Provider LastName | BAYRAKTAR | |
| NPPES Provider FirstName | SOLEY | |
| NPPES Provider ZIPCode | 734011815 | |
| NPPES Provider State | OK | |
| Specialty Description | Hematology | |
| Total Claim Count | 583.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 54.0 | |
| Percent Opioid Claims | 9.26 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437331493 |
| Last Name Of The Provider | BAYRAKTAR |
| First Name Of The Provider | SOLEY |
| View All |
Similar Doctors
|
|
Dr. Ron A. Fattor, MD
 This Doctor is OpenDoctor Recommended.
|